Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Open-Label, Active-Comparator, Blinded-Endpoint, 12-week Forced-Titration Study of the Efficacy and Safety of Nebivolol Verses Metoprolol in Hypertensive Subjects Taking Amlodipine
Conditions
Interventions
Nebivolol I
Nebivolol II
+1 more
Locations
1
United States
Punzi Medical Center
Carrollton, Texas, United States
Start Date
August 30, 2010
Primary Completion Date
May 26, 2011
Completion Date
July 18, 2011
Last Updated
August 20, 2018
Lead Sponsor
Trinity Hypertension & Metabolic Research Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions